Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion type Assertion NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_head.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion description "[In this study we examined the effects of VEGF GT on patients having received VEGF-A gene transfer for the treatment of symptomatic (that is, claudication or critical lower limb ischemia) peripheral arterial occlusive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_provenance.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion evidence source_evidence_literature NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_provenance.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion SIO_000772 21776026 NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_provenance.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion wasDerivedFrom befree-20150227 NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_provenance.
- NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_assertion wasGeneratedBy ECO_0000203 NP772527.RAE2tvnYEYT7gcpB3Cp22fXY86wKs7140_UdF5AcdaYl4130_provenance.